Driven to know precision medicine.

Genetics Portfolio for Inherited Disorders

The Asuragen Genetics portfolio employs our proprietary molecular chemistry and informatics capabilities to drive the evolution of precision medicine in inherited disorders.

The AmplideX® suite of products is designed to solve unmet testing needs in inherited genetic disorders. The technology overcame a 20-year challenge by reliably amplifying the FMR1 gene. This allowed researchers to gain a deeper understanding of fragile X syndrome, the most common known inherited cause of intellectual disability and autism.

Asuragen pioneered innovation in three major areas:

Reduced Complexity
Amplification and analysis of GC-rich and high homology target sequences

Optimized Workflow
Assay and informatics solutions to optimize efficiency, hands-on time and cost

Quality Performance
Accuracy, sensitivity, specificity and reproducibility with FMR1

Back To